Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Total Assets

Arbutus Biopharma Cp Total Assets Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Total Assets from 2010 to 2018.
  • Arbutus Biopharma Cp Total Assets for the quarter ending December 12, 2018 was $228m a -18.48% decrease of -42m year over year
  • Arbutus Biopharma Cp Total Assets for the last 12 months ending December 12, 2018 was $228m a -18.48% decrease of -42m year over year
  • Arbutus Biopharma Cp Annual Total Assets for 2018 was $228m a -4.08% decrease of -9m from 2017
  • Arbutus Biopharma Cp Annual Total Assets for 2017 was $237m a -16.32% decrease of -39m from 2016
  • Arbutus Biopharma Cp Annual Total Assets for 2016 was $276m a -158.15% decrease of -436m from 2015
Other Balance Sheet Metrics:
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Total Equity for the quarter ending December 12, 2018 was $200m a -16.09% decrease of -32m year over year
View Chart On Koyfin

Quarterly ABUS Total Assets Data

12/2018$228m
09/2018$245m
06/2018$277m
03/2018$270m
12/2017$237m
09/2017$240m
06/2017$255m
03/2017$268m
12/2016$276m
09/2016$515m

Annual ABUS Total Assets Data

2018$228m
2017$237m
2016$276m
2015$712m
2014$118m
2013$72m
2012$53m
2011$14m
2010$21m
2009$28m